P-247 Efficacy and safety of linvoseltamab 200 mg in patients with relapsed/refractory multiple myeloma (RRMM): analysis of the LINKER-MM1 study

Dhodapkar, M., Bumma, N., Richter, J., Lee, H., Hoffman, J., Suvannasankha, A., Lentzsch, S., Shah, M., Zonder, J., Baz, R., Wu, K. L., Pianko, M., Silbermann, R., Min, C.-K., Vekemans, M.-C. M., Munder, M., Byun, J. M., Lopez, J. M., DeVeaux, M., … Jagannath, S. (2023). P-247 Efficacy and safety of linvoseltamab 200 mg in patients with relapsed/refractory multiple myeloma (RRMM): analysis of the LINKER-MM1 study. Clinical Lymphoma Myeloma and Leukemia, 23, S172. https://doi.org/10.1016/s2152-2650(23)01865-7
Authors:
Madhav V. Dhodapkar
Naresh Bumma
Joshua Richter
Hans C. Lee
James E. Hoffman
Attaya Suvannasankha
Suzanne Lentzsch
Mansi Shah
Jeffrey A. Zonder
Rachid Baz
Ka Lung Wu
Matthew J. Pianko
Rebecca Silbermann
Chang‐Ki Min
Marie‐Christiane Vekemans
Markus Munder
Ja Min Byun
Joaquín Martínez‐López
Michelle DeVeaux
Karen Rodriguez Lorenc
Glenn Kroog
Yariv Houvras
Sundar Jagannath
Affiliated Authors:
Mansi Shah
Subjects:
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Efficacy and Safety of Antiretroviral Therapy for HIV (OpenAlex Topic)
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)01865-7
DOI:
10.1016/s2152-2650(23)01865-7
Journal:
Clinical Lymphoma, Myeloma and Leukemia
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: